MAPT and Alzheimer disease: In Alzheimer’s disease, this contributes to a decrease in amyloid-β clearance and subsequent increase in amyloid-β and tau aggregation23, as well as activation of microglia, astrocyte reactivity, and pericyte shedding24, which further destabilises the BBB.